{"product_id":"essentials-of-medical-pharmacology-9th-edition-revised-reprint","title":"Essentials of Medical Pharmacology, 9th Edition (Revised Reprint)","description":"\u003cp\u003epharmacology learning for medical students across India and neighbouring countries for more than four decades. Revised in accordance with the NMC's Competency-Based Medical Education (CBME) Curriculum 2024, it carries a carefully balanced blend of core pharmacology, clinical application and current therapeutics across 14 Sections, with learning objectives opening every chapter.\u003c\/p\u003e\u003cp\u003eThis edition is markedly more clinical than its predecessors. Core concepts are tied to practice through 118 cases for case-based learning and clinical insight boxes, so students learn not only what a drug does but when, why and how it is used. Recommendations from WHO, ACC\/AHA, ISH, NICE, SIGN and GINA, together with meta-analyses and landmark clinical trials, underpin the therapeutic guidance.\u003c\/p\u003e\u003cp\u003eThe presentation is built for understanding and recall: revised tables, flowcharts, line diagrams and boxes highlight essential facts, comparisons and therapeutic principles, with important abbreviations gathered into a single reference section. Dedicated AETCOM modules bring ethical, communication and professional dimensions into pharmacological learning through clinical case scenarios.\u003c\/p\u003e\u003cp\u003eWhat's New in This Edition:\u003c\/p\u003e\u003cp\u003eFully aligned with the CBME Curriculum 2024: pharmacology presented against the revised NMC competencies, with learning objectives in each chapter and integrated pharmacology-related AETCOM modules.\u003c\/p\u003e\u003cp\u003e118 cases for case-based learning: core concepts linked to clinical application through patient-based scenarios and clinical insight boxes that answer the 'why' behind a prescription.\u003c\/p\u003e\u003cp\u003eLatest drugs and therapeutic advances: GLP-1 receptor agonists, SGLT-2 inhibitors, neprilysin inhibitors, orexin antagonists, PCSK9 inhibitors, CGRP antagonists and other newer drugs.\u003c\/p\u003e\u003cp\u003eUpdated treatment algorithms: for diabetes, hypertension, heart failure, tuberculosis, cardiac arrest, infertility, peripheral vascular disease and asthma among others.\u003c\/p\u003e\u003cp\u003eEvidence-based pharmacotherapy: supported by WHO, ACC\/AHA, ISH, NICE, SIGN and GINA recommendations, meta-analyses and landmark clinical trials.\u003c\/p\u003e\u003cp\u003eCurrent National Health Programme guidelines: incorporated for tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis and viral hepatitis.\u003c\/p\u003e\u003cp\u003eExpanded antimicrobial stewardship: updated to include the WHO AWaRe classification of antibiotics.\u003c\/p\u003e\u003cp\u003eDedicated Pharmacovigilance Programme of India coverage: drug safety monitoring and rational therapeutic practice.\u003c\/p\u003e\u003cp\u003eRecent advances in therapeutics: biologics, monoclonal antibodies, newer vaccines, immunomodulators and gene and cell-based therapies, with new classifications and figures.\u003c\/p\u003e\u003cp\u003eStrengthened updates on core competencies: prescription writing, essential medicines, management of poisoning and therapeutic drug monitoring.\u003c\/p\u003e","brand":"southindiabookagency","offers":[{"title":"Default Title","offer_id":45880536531079,"sku":"9788167999641","price":1421.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0742\/6736\/1415\/files\/1qiM2RmSLcxBFqavvYB9_xy5cOSgVnFS3_w1600.jpg?v=1789671218","url":"https:\/\/www.southindiabookagency.com\/products\/essentials-of-medical-pharmacology-9th-edition-revised-reprint","provider":"South India Book Agency","version":"1.0","type":"link"}